Advertisement
New Zealand markets closed
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NZD/USD

    0.5961
    +0.0024 (+0.40%)
     
  • NZD/EUR

    0.5554
    +0.0008 (+0.15%)
     
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • OIL

    82.83
    +0.02 (+0.02%)
     
  • GOLD

    2,337.90
    -0.50 (-0.02%)
     
  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     
  • FTSE

    8,088.98
    +48.60 (+0.60%)
     
  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     
  • DAX

    17,974.51
    -114.19 (-0.63%)
     
  • Hang Seng

    17,284.54
    +83.27 (+0.48%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • NZD/JPY

    92.7300
    +0.6150 (+0.67%)
     

Got $1,000? Check Out These 3 Top Biotech Stocks

Got $1,000? Check Out These 3 Top Biotech Stocks

Here's why they chose Vertex Pharmaceuticals (NASDAQ: VRTX), Gilead Sciences (NASDAQ: GILD), and Beam Therapeutics (NASDAQ: BEAM). Prosper Junior Bakiny (Vertex Pharmaceuticals): Shares of Vertex Pharmaceuticals, a biotech that focuses on developing treatments for rare diseases, have significantly lagged the market over the past year.